Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Preferred Shares (2016 - 2025)

CorMedix has reported Preferred Shares over the past 12 years, most recently at $92.0 for Q3 2025.

  • Quarterly results put Preferred Shares at $92.0 for Q3 2025, down 49.45% from a year ago — trailing twelve months through Sep 2025 was $92.0 (down 49.45% YoY), and the annual figure for FY2024 was $137.0, down 24.73%.
  • Preferred Shares reached $92.0 in Q3 2025 per CRMD's latest filing, roughly flat from $92.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $182.0 in Q1 2021 and bottomed at $92.0 in Q1 2025.
  • Median Preferred Shares over the past 5 years was $182.0 (2021), compared with a mean of $165.42.
  • The largest annual shift saw Preferred Shares changed 0.0% in 2022 before it crashed 49.45% in 2025.
  • Over 5 years, Preferred Shares stood at $182.0 in 2021, then changed by 0.0% to $182.0 in 2022, then changed by 0.0% to $182.0 in 2023, then decreased by 24.73% to $137.0 in 2024, then tumbled by 32.85% to $92.0 in 2025.
  • Business Quant data shows Preferred Shares for CRMD at $92.0 in Q3 2025, $92.0 in Q2 2025, and $92.0 in Q1 2025.